“It’s not just about slowing aging down or stopping it, it’s about bringing yourself back to a younger biological age, which is effectively age reversal.”
Daniel Ives, founder of Shift Bioscience, introduces their transcriptomic driver clock which enables them to identify putative drug targets for safer cellular rejuvenation, which might avoid the challenges coupled to therapeutic use of Yamanaka factors. Daniel goes into detail on what the clock enables, how they are planning to validate these putative targets, his wishlist for tools that could help speed up and de-risk longevity and aging focused drug development.
I Knew a Guy by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/
Remarks: The length of this recording has been altered.